Equillium, Inc. (EQ)
1.92
-0.09
(-4.48%)
USD |
NASDAQ |
Apr 07, 16:00
1.94
+0.02
(+1.04%)
After-Hours: 20:00
Equillium EPS Diluted (Quarterly) : -0.0411 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Terns Pharmaceuticals, Inc. | -0.2395 |
| Cognition Therapeutics, Inc. | -0.0376 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.775M |
| Total Expenses (Quarterly) | 3.775M |
| Enterprise Value | 91.84M |
| Earnings Yield | -27.51% |
| Normalized Earnings Yield | -27.50 |